F755-0153 Screening compound: N~2~-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}-2-furamide

F755-0153 Screening compound: N~2~-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}-2-furamide
F755-0153 Screening compound: N~2~-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}-2-furamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F755-0153
N~2~-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}-2-furamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F755-0153

Molecular Formula

C21H18N6O3 (C21 H18 N6 O3)

Compound Name

N~2~-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-{[6-oxopyrido[2,3-e]pyrrolo[1,2-a]pyrazin-5(6H)-yl]methyl}-2-furamide

IUPAC name

N-[(3-methyl-1H-pyrazol-4-yl)methyl]-5-({7-oxo-2810-triazatricyclo[7.4.0.0^{26}]trideca-1(13)35911-pentaen-8-yl}methyl)furan-2-carboxamide

SMILES

Cc1n[nH]cc1CNC(c1ccc(CN(C2=O)c3ncccc3-n3c2ccc3)o1)=O

InChI

InChI=1S/C21H18N6O3/c1-13-14(11-24-25-13)10-23-20(28)18-7-6-15(30-18)12-27-19-16(4-2-8-22-19)26-9-3-5-17(26)21(27)29/h2-9,11H,10,12H2,1H3,(H,23,28)(H,24,25)

InChI Key

XVJLFSDPGJEUGV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27189184

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

402.41

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.160

Distribution Coefficient, logD

2.160

Water Solubility, LogSw

-2.48

Polar Surface Area

83.819

Acid Dissociation Constant (pKa)

13.53

Base Dissociation Constant (pKb)

1.97

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

F755-0153 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with F755-0153 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F755-0153?
Check Price and Availability of F755-0153, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F755-0153 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F755-0153
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F755-0153
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F755-0153 available by request